Estrella Immunopharma, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Estrella Immunopharma, Inc. reported Cash And Cash Equivalents At Carrying Value of $1.38 million for the year ending 2025.

  • Estrella Immunopharma, Inc. showed an increase of +51.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Estrella Immunopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2021 to 2025), Estrella Immunopharma, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 189.1%.
  • Historical annual values: Fiscal year 2025: $1.38 million | Fiscal year 2024: $916.9 thousand | Fiscal year 2024: $4.17 million | Fiscal year 2023: $2.48 million | Fiscal year 2022: $40.8 thousand | Fiscal year 2021: $478.9 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: